Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats
Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated. This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolep...
Saved in:
Published in | Psychopharmacologia Vol. 192; no. 4; pp. 571 - 580 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Berlin
Springer
01.07.2007
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0033-3158 1432-2072 |
DOI | 10.1007/s00213-007-0753-8 |
Cover
Abstract | Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated.
This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-D-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking.
Wistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 microg/side), the NMDA antagonist D-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 microg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 microg/side) on reinstatement were examined in a within-subjects design.
CNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets.
The results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior. |
---|---|
AbstractList | Rationale: Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated. Objective: This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-d-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking. Method: Wistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 mu g/side), the NMDA antagonist d-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 mu g/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 mu g/side) on reinstatement were examined in a within-subjects design. Results: CNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets. Conclusions: The results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior. RATIONALE: Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated. OBJECTIVE: This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-D-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking. METHOD: Wistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 microg/side), the NMDA antagonist D-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 microg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 microg/side) on reinstatement were examined in a within-subjects design. RESULTS: CNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets. CONCLUSIONS: The results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior. [PUBLICATION ABSTRACT] RationaleNucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated.ObjectiveThis study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-d-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking.MethodWistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 μg/side), the NMDA antagonist d-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 μg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 μg/side) on reinstatement were examined in a within-subjects design.ResultsCNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets.ConclusionsThe results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior. Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated. This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-D-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking. Wistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 microg/side), the NMDA antagonist D-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 microg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 microg/side) on reinstatement were examined in a within-subjects design. CNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets. The results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior. Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated.RATIONALENucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking maintained by drug-associated cues has not been fully investigated.This study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-D-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking.OBJECTIVEThis study examined the effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate, N-methyl-D-aspartate (NMDA) and mGlu5 receptor blockade in the nucleus accumbens core on cue-induced reinstatement of cocaine seeking.Wistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 microg/side), the NMDA antagonist D-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 microg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 microg/side) on reinstatement were examined in a within-subjects design.METHODWistar rats were trained to self-administer cocaine and associate a compound stimulus (light and tone) with the drug under an FR4(FR5:S) second-order schedule of reinforcement. After extinction, during which neither cocaine nor the compound stimulus was available, responding was reinstated by contingent presentations of the compound stimulus. The effects of the intra-accumbal AMPA/kainate receptor antagonist 6-cyano-7-nitro-quinoxaline-2, 3-dione (CNQX; 0, 0.01, and 0.03 microg/side), the NMDA antagonist D-2-amino-5-phosphonopentanoate (D-AP5; 0, 1, and 2 microg/side), and the mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 0.5, and 1 microg/side) on reinstatement were examined in a within-subjects design.CNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets.RESULTSCNQX and D-AP5 attenuated cue-induced reinstatement of cocaine seeking dose-dependently. MPEP, however, decreased cocaine seeking only relative to baseline because also the saline vehicle included in the within-subjects series of injections decreased responding, possibly reflecting conditioned anhedonic effects of MPEP. In additional experiments, none of the antagonists attenuated locomotor activity or responding for sucrose pellets.The results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior.CONCLUSIONSThe results suggest that cue-induced reinstatement of cocaine seeking after a period of withdrawal from cocaine is sensitive to AMPA/kainate and NMDA receptor antagonism in the nucleus accumbens core and give further evidence for the role of the accumbal glutamate transmission in modulation of drug-seeking behavior. |
Author | Hyytiä, Petri Bäckström, Pia |
Author_xml | – sequence: 1 givenname: Pia surname: Baeckstroem fullname: Baeckstroem, Pia – sequence: 2 givenname: Petri surname: Hyytiae fullname: Hyytiae, Petri |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18834204$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17347848$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0k9rFTEQAPAgFfta_QBeJCj21Nj82032-GhtLbTqQc9LNjuraXeTZ7Ip9Dv4oc3yXikU1FwSmN_MEGYO0J4PHhB6zegHRqk6SZRyJkh5EqoqQfQztGJScMKp4ntoRakQRLBK76ODlG5oOVLLF2ifKSGVlnqFfl_6uzDewQR-xmHA6-uv65Nb47yZ4Rh_vj5bH2PjezxdjLnCESxs5hATdh7PPwH7bEfICRtr89SBT9iGCEvUZiDO99lCX9KcT3Op-NDFBltaAE4At87_WHw0c3qJng9mTPBqdx-i7-cfv51-IldfLi5P11fESlbNRFS1kKDqjvFGdn3HwRgmtOqF6pSUPR9YpUSJguZDDY0wPa3BDrpr7ACMikN0tK27ieFXhjS3k0sWxtF4CDm1ilZ1Iyn_L2RN3ZTOrMB3T-BNyNGXT7S8riuhqZR1UW__qphuilOyoDc7lLsJ-nYT3WTiffswswLe74BJ1oxDNN669Oi0FpLTpRDbOhtDShGGR0LbZX_a7f60y3PZn3aprZ7kWFcG54Kfo3HjPzL_AEiwx0M |
CODEN | PSYPAG |
CitedBy_id | crossref_primary_10_1016_j_tips_2017_12_004 crossref_primary_10_1016_j_ejphar_2010_01_029 crossref_primary_10_1038_npp_2010_48 crossref_primary_10_1016_j_neulet_2020_135470 crossref_primary_10_1111_gbb_12348 crossref_primary_10_1002_wmts_18 crossref_primary_10_1007_s00213_016_4384_9 crossref_primary_10_1016_j_bbr_2009_03_039 crossref_primary_10_1016_j_jgr_2021_05_007 crossref_primary_10_1523_ENEURO_0029_21_2021 crossref_primary_10_1016_j_brainres_2008_02_106 crossref_primary_10_1038_nrn2515 crossref_primary_10_1101_cshperspect_a039628 crossref_primary_10_3389_fnbeh_2018_00017 crossref_primary_10_1111_j_1476_5381_2010_01088_x crossref_primary_10_1126_sciadv_abo6574 crossref_primary_10_1007_s00213_011_2565_0 crossref_primary_10_1111_j_1369_1600_2011_00325_x crossref_primary_10_12659_MSM_881802 crossref_primary_10_1007_s00213_012_2897_4 crossref_primary_10_1111_j_1471_4159_2008_05518_x crossref_primary_10_1196_annals_1441_013 crossref_primary_10_1016_j_neuropharm_2021_108452 crossref_primary_10_1111_adb_12122 crossref_primary_10_1111_ejn_12491 crossref_primary_10_1016_j_brainresbull_2011_10_021 crossref_primary_10_1016_j_neuropharm_2018_07_003 crossref_primary_10_1111_adb_12127 crossref_primary_10_1124_pr_116_012484 crossref_primary_10_1111_jnc_13524 crossref_primary_10_1007_s00213_013_3106_9 crossref_primary_10_1111_j_1471_4159_2010_06851_x crossref_primary_10_1007_s00213_010_1868_x crossref_primary_10_1016_j_euroneuro_2008_04_010 crossref_primary_10_1007_s00213_008_1234_4 crossref_primary_10_1111_j_1471_4159_2009_06140_x crossref_primary_10_1016_j_neuropharm_2024_110081 crossref_primary_10_1523_JNEUROSCI_1264_10_2010 crossref_primary_10_1111_j_1460_9568_2012_07991_x crossref_primary_10_1016_j_brainres_2007_09_035 crossref_primary_10_1016_j_pharmthera_2009_11_002 crossref_primary_10_1038_npp_2008_140 crossref_primary_10_1016_j_neubiorev_2017_02_024 crossref_primary_10_1016_j_brainres_2014_09_004 crossref_primary_10_1007_s00213_010_1890_z crossref_primary_10_1016_j_bbr_2010_08_012 crossref_primary_10_1523_JNEUROSCI_0503_13_2013 crossref_primary_10_1016_j_biopsych_2009_09_016 crossref_primary_10_3389_fnbeh_2023_1305412 crossref_primary_10_1111_bph_12735 crossref_primary_10_1093_ijnp_pyw086 crossref_primary_10_1016_j_neubiorev_2022_104584 crossref_primary_10_1016_j_bbr_2017_06_017 crossref_primary_10_1016_j_neuropharm_2017_12_008 crossref_primary_10_1371_journal_pone_0068371 crossref_primary_10_1523_JNEUROSCI_1432_21_2022 crossref_primary_10_1111_adb_12740 crossref_primary_10_1007_s00213_013_3226_2 crossref_primary_10_1016_j_neuroscience_2008_05_015 crossref_primary_10_1038_npp_2013_175 crossref_primary_10_1016_j_bcp_2007_07_031 crossref_primary_10_1016_j_cobeha_2018_06_014 crossref_primary_10_1016_j_brs_2021_11_003 crossref_primary_10_1111_j_1749_6632_2009_05144_x crossref_primary_10_1124_jpet_117_244822 crossref_primary_10_1016_j_pbb_2010_06_005 crossref_primary_10_1016_j_addbeh_2010_11_003 crossref_primary_10_1007_s00429_015_1170_0 crossref_primary_10_1007_s10571_022_01223_6 crossref_primary_10_1016_j_brainres_2012_05_014 crossref_primary_10_1038_nn_3445 crossref_primary_10_1007_s00213_019_05208_0 crossref_primary_10_1007_s00213_011_2447_5 crossref_primary_10_1038_npp_2015_92 crossref_primary_10_1111_j_1369_1600_2011_00432_x crossref_primary_10_1523_JNEUROSCI_1221_08_2008 crossref_primary_10_1111_j_1530_0277_2009_01030_x crossref_primary_10_1016_j_mehy_2008_03_043 crossref_primary_10_1111_adb_12690 crossref_primary_10_1021_jm900172f crossref_primary_10_1007_s00213_009_1624_2 crossref_primary_10_1016_j_bbr_2008_09_027 crossref_primary_10_1038_sj_npp_1301473 crossref_primary_10_1007_s00213_009_1700_7 crossref_primary_10_1523_JNEUROSCI_3710_12_2013 crossref_primary_10_1523_JNEUROSCI_5129_07_2008 crossref_primary_10_1038_s41598_019_51556_4 crossref_primary_10_3390_healthcare9040376 crossref_primary_10_1007_s00213_007_0904_y crossref_primary_10_1111_bph_13437 crossref_primary_10_1016_j_biopsych_2012_07_019 crossref_primary_10_1016_j_neuron_2010_06_004 crossref_primary_10_1016_j_pbb_2012_01_014 crossref_primary_10_1016_j_neulet_2012_07_042 crossref_primary_10_1016_j_neubiorev_2020_07_025 crossref_primary_10_1038_bjp_2008_51 crossref_primary_10_1016_j_bbr_2016_08_011 crossref_primary_10_1007_s00213_012_2804_z crossref_primary_10_4196_kjpp_2021_25_1_79 crossref_primary_10_1038_mp_2011_46 crossref_primary_10_1016_j_jneuroim_2011_06_002 crossref_primary_10_1523_JNEUROSCI_3236_14_2014 crossref_primary_10_1523_JNEUROSCI_2550_10_2010 crossref_primary_10_1016_j_biopsych_2014_02_005 crossref_primary_10_1038_sj_npp_1301623 crossref_primary_10_1016_j_neuropharm_2012_08_006 crossref_primary_10_1016_j_pharmthera_2012_01_010 crossref_primary_10_1111_j_1460_9568_2008_06199_x crossref_primary_10_1007_s12035_014_8926_z crossref_primary_10_1007_s12640_014_9502_z crossref_primary_10_1016_j_bcp_2007_06_039 crossref_primary_10_1038_s41598_018_22087_1 crossref_primary_10_1007_s12640_010_9176_0 crossref_primary_10_1124_pharmrev_121_000540 crossref_primary_10_1124_pr_109_001933 crossref_primary_10_1016_j_coph_2008_12_003 crossref_primary_10_1098_rstb_2008_0084 |
Cites_doi | 10.1007/s00213-002-1328-3 10.1016/S0893-133X(99)00157-8 10.1038/sj.mp.4001269 10.1046/j.0953-816x.2001.01804.x 10.1002/syn.10166 10.1523/JNEUROSCI.22-07-02916.2002 10.1007/s00213-001-0953-6 10.1007/s002130050774 10.1038/sj.npp.1300845 10.1111/j.1471-4159.2005.03517.x 10.1016/S0149-7634(02)00007-6 10.1046/j.1471-4159.1999.0722397.x 10.1523/JNEUROSCI.21-21-08655.2001 10.1038/nn1579 10.1016/S0893-133X(00)00100-7 10.1007/s00213-004-2069-2 10.1007/BF02245266 10.1016/S0306-4522(99)00214-6 10.1007/s002139900340 10.1016/S0028-3908(02)00309-X 10.1177/026988119801200104 10.1101/lm.81404 10.1007/s00213-002-1224-x 10.1038/sj.npp.1300381 10.1016/j.drugalcdep.2006.04.003 10.1038/nn1383 10.1523/JNEUROSCI.2252-05.2005 10.1038/nn1217 10.1007/s00213-002-1196-x 10.1016/j.ejphar.2005.09.034 10.1046/j.1471-4159.2003.01824.x 10.1001/archpsyc.58.4.334 10.1523/JNEUROSCI.20-15-j0006.2000 10.1007/s00213-004-1895-6 10.1038/sj.npp.1300851 10.1176/appi.ajp.158.7.1075 10.1016/0301-0082(80)90018-0 10.1523/JNEUROSCI.23-08-03531.2003 10.1016/S0893-133X(01)00235-4 10.1523/JNEUROSCI.23-03-00742.2003 10.1007/s00213-003-1432-z |
ContentType | Journal Article |
Copyright | 2007 INIST-CNRS Springer-Verlag 2007 Springer-Verlag 2007. |
Copyright_xml | – notice: 2007 INIST-CNRS – notice: Springer-Verlag 2007 – notice: Springer-Verlag 2007. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
DOI | 10.1007/s00213-007-0753-8 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Chemoreception Abstracts Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Psychology Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Animal Behavior Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Neurosciences Abstracts ProQuest One Psychology ProQuest One Psychology MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1432-2072 |
EndPage | 580 |
ExternalDocumentID | 1282661481 17347848 18834204 10_1007_s00213_007_0753_8 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | .55 3SX 40D 40E 95. 95~ AAYXX ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS CITATION KOW N2Q R9- RHV SBY SOJ X7M ~EX -4W -BR IQODW CGR CUY CVF ECM EIF NPM 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GNUQQ K9. M1P M2M NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
ID | FETCH-LOGICAL-c415t-35634e76b1294bdb2eaa1387d37b744d2f1573b12e82f6e93ad06ecf8b9cfe103 |
IEDL.DBID | 7X7 |
ISSN | 0033-3158 |
IngestDate | Fri Jul 11 11:18:14 EDT 2025 Fri Jul 11 01:01:29 EDT 2025 Sun Aug 17 09:11:17 EDT 2025 Sun Aug 17 09:11:22 EDT 2025 Sat Sep 28 08:19:45 EDT 2024 Tue Sep 20 22:41:05 EDT 2022 Tue Jul 01 04:16:30 EDT 2025 Thu Apr 24 23:03:26 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Agonist Relapse Rat Psychotropic Central nervous system Glutamate receptor Encephalon Kainate receptor Ester Drug of abuse Conditioning Glutamate receptors mglu5 glutamate receptor CNS stimulant Rodentia Basal ganglion Nucleus accumbens Vertebrata Mammalia Addiction Metabotropic receptor Animal Cocaine NMDA receptor Kainic acid |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c415t-35634e76b1294bdb2eaa1387d37b744d2f1573b12e82f6e93ad06ecf8b9cfe103 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 17347848 |
PQID | 218965374 |
PQPubID | 47309 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_70569402 proquest_miscellaneous_19691381 proquest_journals_2665380446 proquest_journals_218965374 pubmed_primary_17347848 pascalfrancis_primary_18834204 crossref_primary_10_1007_s00213_007_0753_8 crossref_citationtrail_10_1007_s00213_007_0753_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007-07-01 |
PublicationDateYYYYMMDD | 2007-07-01 |
PublicationDate_xml | – month: 07 year: 2007 text: 2007-07-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Berlin |
PublicationPlace_xml | – name: Berlin – name: Germany – name: Heidelberg |
PublicationTitle | Psychopharmacologia |
PublicationTitleAlternate | Psychopharmacology (Berl) |
PublicationYear | 2007 |
Publisher | Springer Springer Nature B.V |
Publisher_xml | – name: Springer – name: Springer Nature B.V |
References | WK Park (753_CR34) 2002; 22 P Bäckström (753_CR3) 2004; 29 NE Paterson (753_CR35) 2003; 167 L Lu (753_CR27) 2003; 85 RE See (753_CR39) 2005; 526 JL Cornish (753_CR10) 1999; 93 JL Cornish (753_CR9) 2000; 20 K McFarland (753_CR30) 2003; 23 Y Shaham (753_CR41) 2003; 161 RW Foltin (753_CR14) 2000; 149 L Lu (753_CR28) 2005; 8 CD Kilts (753_CR24) 2001; 58 G Paxinos (753_CR36) 1997 PJ Kenny (753_CR23) 2005; 179 AA Harrison (753_CR18) 2002; 160 JW Grimm (753_CR17) 2003; 23 F Schneider (753_CR38) 2001; 158 G Hotsenpiller (753_CR21) 2001; 14 J McLaughlin (753_CR32) 2003; 168 P Bäckström (753_CR2) 2006; 31 P Di Ciano (753_CR11) 2001; 25 L Churchill (753_CR8) 1999; 72 AC Boudreau (753_CR5) 2005; 25 ST Tiffany (753_CR42) 1998; 12 K McFarland (753_CR29) 2001; 21 RA Fuchs (753_CR15) 2004; 176 M Arroyo (753_CR1) 1998; 140 RJ Hayes (753_CR19) 2003; 168 SB Caine (753_CR6) 1993 R Ito (753_CR22) 2004; 7 RN Cardinal (753_CR7) 2002; 26 BJ Everitt (753_CR13) 2005; 8 GJ Mogenson (753_CR33) 1980; 14 K Bell (753_CR4) 2000; 23 DW Self (753_CR40) 2004; 11 TM Tzschentke (753_CR43) 2003; 8 JW Grimm (753_CR16) 2000; 22 TR Kosten (753_CR25) 2006; 31 AJ McGeehan (753_CR31) 2003; 47 RN Ehrman (753_CR12) 1992; 107 SE Hemby (753_CR20) 2005; 95 KD Lominac (753_CR26) 2006; 85 P Popik (753_CR37) 2002; 43 |
References_xml | – volume: 168 start-page: 75 year: 2003 ident: 753_CR19 publication-title: Psychopharmacology doi: 10.1007/s00213-002-1328-3 – volume: 22 start-page: 473 year: 2000 ident: 753_CR16 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(99)00157-8 – volume: 8 start-page: 373 year: 2003 ident: 753_CR43 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001269 – volume: 14 start-page: 1843 year: 2001 ident: 753_CR21 publication-title: Eur J Neurosci doi: 10.1046/j.0953-816x.2001.01804.x – volume: 47 start-page: 240 year: 2003 ident: 753_CR31 publication-title: Synapse doi: 10.1002/syn.10166 – volume: 22 start-page: 2916 year: 2002 ident: 753_CR34 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.22-07-02916.2002 – start-page: 117 volume-title: Behavioral neuroscience: a practical approach year: 1993 ident: 753_CR6 – volume: 160 start-page: 56 year: 2002 ident: 753_CR18 publication-title: Psychopharmacology doi: 10.1007/s00213-001-0953-6 – volume: 140 start-page: 331 year: 1998 ident: 753_CR1 publication-title: Psychopharmacology doi: 10.1007/s002130050774 – volume: 31 start-page: 778 year: 2006 ident: 753_CR2 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300845 – volume: 95 start-page: 1785 year: 2005 ident: 753_CR20 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2005.03517.x – volume: 26 start-page: 321 year: 2002 ident: 753_CR7 publication-title: Neurosci Biobehav Rev doi: 10.1016/S0149-7634(02)00007-6 – volume: 72 start-page: 2397 year: 1999 ident: 753_CR8 publication-title: J Neurochem doi: 10.1046/j.1471-4159.1999.0722397.x – volume: 21 start-page: 8655 year: 2001 ident: 753_CR29 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.21-21-08655.2001 – volume: 8 start-page: 1481 year: 2005 ident: 753_CR13 publication-title: Nat Neurosci doi: 10.1038/nn1579 – volume: 23 start-page: 335 year: 2000 ident: 753_CR4 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(00)00100-7 – volume: 179 start-page: 247 year: 2005 ident: 753_CR23 publication-title: Psychopharmacology doi: 10.1007/s00213-004-2069-2 – volume: 107 start-page: 523 year: 1992 ident: 753_CR12 publication-title: Psychopharmacology doi: 10.1007/BF02245266 – volume: 93 start-page: 1359 year: 1999 ident: 753_CR10 publication-title: Neuroscience doi: 10.1016/S0306-4522(99)00214-6 – volume: 149 start-page: 24 year: 2000 ident: 753_CR14 publication-title: Psychopharmacology doi: 10.1007/s002139900340 – volume: 43 start-page: 1210 year: 2002 ident: 753_CR37 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(02)00309-X – volume: 12 start-page: 23 year: 1998 ident: 753_CR42 publication-title: J Psychopharmacol doi: 10.1177/026988119801200104 – volume: 11 start-page: 648 year: 2004 ident: 753_CR40 publication-title: Learn Mem doi: 10.1101/lm.81404 – volume: 161 start-page: 3 year: 2003 ident: 753_CR41 publication-title: Psychopharmacology doi: 10.1007/s00213-002-1224-x – volume: 29 start-page: 921 year: 2004 ident: 753_CR3 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300381 – volume: 85 start-page: 142 year: 2006 ident: 753_CR26 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2006.04.003 – volume: 8 start-page: 212 year: 2005 ident: 753_CR28 publication-title: Nat Neurosci doi: 10.1038/nn1383 – volume-title: The rat brain in stereotaxic coordinates year: 1997 ident: 753_CR36 – volume: 25 start-page: 9144 year: 2005 ident: 753_CR5 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2252-05.2005 – volume: 7 start-page: 389 year: 2004 ident: 753_CR22 publication-title: Nat Neurosci doi: 10.1038/nn1217 – volume: 168 start-page: 57 year: 2003 ident: 753_CR32 publication-title: Psychopharmacology doi: 10.1007/s00213-002-1196-x – volume: 526 start-page: 140 year: 2005 ident: 753_CR39 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2005.09.034 – volume: 85 start-page: 1604 year: 2003 ident: 753_CR27 publication-title: J Neurochem doi: 10.1046/j.1471-4159.2003.01824.x – volume: 58 start-page: 334 year: 2001 ident: 753_CR24 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.58.4.334 – volume: 20 start-page: 1 year: 2000 ident: 753_CR9 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.20-15-j0006.2000 – volume: 176 start-page: 459 year: 2004 ident: 753_CR15 publication-title: Psychopharmacology doi: 10.1007/s00213-004-1895-6 – volume: 31 start-page: 644 year: 2006 ident: 753_CR25 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300851 – volume: 158 start-page: 1075 year: 2001 ident: 753_CR38 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.158.7.1075 – volume: 14 start-page: 69 year: 1980 ident: 753_CR33 publication-title: Prog Neurobiol doi: 10.1016/0301-0082(80)90018-0 – volume: 23 start-page: 3531 year: 2003 ident: 753_CR30 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.23-08-03531.2003 – volume: 25 start-page: 341 year: 2001 ident: 753_CR11 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(01)00235-4 – volume: 23 start-page: 742 year: 2003 ident: 753_CR17 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.23-03-00742.2003 – volume: 167 start-page: 257 year: 2003 ident: 753_CR35 publication-title: Psychopharmacology doi: 10.1007/s00213-003-1432-z |
SSID | ssj0000484 ssj0068394 |
Score | 2.2798622 |
Snippet | Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug seeking... RATIONALE: Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug... RationaleNucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug... Rationale: Nucleus accumbens glutamate transmission has been implicated in drug-seeking behavior, but the involvement of glutamate receptor subtypes in drug... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 571 |
SubjectTerms | 2-Amino-5-phosphonovalerate - pharmacology 6-Cyano-7-nitroquinoxaline-2,3-dione - pharmacology Animal behavior Animal memory Animal training Animals Biological and medical sciences Cocaine Cocaine - administration & dosage Cocaine-Related Disorders - physiopathology Cocaine-Related Disorders - psychology Conditioning, Psychological - drug effects Cues Dopamine Uptake Inhibitors - administration & dosage Dose-Response Relationship, Drug Drug abuse Drug addiction Excitatory Amino Acid Antagonists - pharmacology Extinction, Psychological - drug effects Glutamic acid receptors Glutamic acid receptors (ionotropic) Glutamic acid receptors (metabotropic) Locomotor activity Male Medical sciences Motor Activity - drug effects N-Methyl-D-aspartic acid receptors Neuropharmacology Neurotransmitters Nucleus accumbens Nucleus Accumbens - drug effects Nucleus Accumbens - physiopathology Pharmacology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Pyridines - pharmacology Quinoxaline Rats Rats, Wistar Receptor, Metabotropic Glutamate 5 Receptors, Kainic Acid - antagonists & inhibitors Receptors, Kainic Acid - physiology Receptors, Metabotropic Glutamate - antagonists & inhibitors Receptors, Metabotropic Glutamate - physiology Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors Receptors, N-Methyl-D-Aspartate - physiology Reinstatement Rodents Second-order schedule Self Administration Sucrose α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid |
Title | Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats |
URI | https://www.ncbi.nlm.nih.gov/pubmed/17347848 https://www.proquest.com/docview/218965374 https://www.proquest.com/docview/2665380446 https://www.proquest.com/docview/19691381 https://www.proquest.com/docview/70569402 |
Volume | 192 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1da9swFBVbC2NQxtZ9ee0yPYw-jJhKlizJTyPZmnWDhDBayJuxZQnKOied44f-h_3o3euPmMLapzhcCRtf6epI1_ccQj66PLYZ9yyMTeFgg1Ko0HChwiSKXMQzDzERC5znC3V-KX-s4lX3bU7VfVbZx8QmUBdri2fkp7AUJSoWWn7e3IQoGoXJ1U5B4zHZ5wBEULlBr_QQiCXWYLZ_FACBlpFZYD1ZbPoMJ2sIRSPUOGgO7WIRmjtr1MEmq-B1-Vbn4n4g2ixIs-fkWYck6aR1_QvyyJWH5Mm8y5UfkpNly0p9O6YXQ5FVNaYndDnwVd--JH-_lxCjGt7wLV17OpkvJ6e_sKpq68Z0Mf86GdOsLOjvb9d1TCFCug1K9NCrkgJ6pCUyItcVzaxFdZGyosiMiVZbuxC2_DB4Cuh2VTbFS_1dIBDDLRytnMPTemwPg7F6RS5nZxdfzsNOpCG0sPZvQxErIZ1WOQAHmRd55LKMC6MLoXMtZRF5HmsBVmcir1wisoIpZ73JE-sdZ-I12SvXpXtLaJJ5FXsOmJFJ6ZlJwE1a58JyaVmes4Cw3i2p7RjMUUjjOt1xLzeeTPESPZmagHzaddm09B0PNR7d8fXQwxghIyYDctQ7P-2mepXuBmZAjv9jVWAzmDUPyIedGaYw5mWy0q3rKkWGInhl_P4WGmBqAjv9gLxph9zwaFpIbaR59-CjHZGn_Zk048dkb_undu8BTG3zUTNlRmR_MptOF_A7PVssf_4DQJUccw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEB2VVAIkhKDcTEu7D9AHFKvr3bW9fqhQoC0JbaIItVLfjC-7UkRxAk6E8g_8Ev_GjC-JKtG-9S3R7MZWzu7MeMdzDsBbk_pZ4lnu-jo3-ICSB672ZOBGQhjhJRZ9IjU4D0dB_0J9ufQvN-Bv2wtDr1W2PrFy1Pk0ozPyAwxFUeDLUH2Y_XRJNIqKq62CRtIoK-SHFcNY09dxapa_8QmuPBwcIdzvhDg5Pv_UdxuRATfD2DV3pR9IZcIgxcCn0jwVJkk8qcNchmmoVC6s54cSrUYLG5hIJjkPTGZ1GmXWeFzi796DTUXnJx3Y_Hg8Gn9dhwJFXaD1lwBTkZoTWlJHm6_bGiuvKE0FqSxUx4a-dPW1KPlolpQImK2VNm5OhauQePIEHje5LOvVi-8pbJhiC-4Pm2r9FuyPa17sZZedr9u8yi7bZ-M1Y_byGfwZFOglK-byOZta1huOewffqa9rbrpsNDzqdVlS5OzH56uFz9BHmxmJBLFJwTB_ZQVxMi9KhviQvklRMuLmJGu2MO6kyHH55jhtUlTtU-1VMBTgJQwrjaF6AY3H7VA-h4s7QfAFdIppYV4BixIb-NbDrJUrZbmOEKYwTGXmqYynKXeAt7DEWcOhTlIeV_GK_blCMqaPhGSsHXi_mjKrCURuG7x7Dev1DK2lElw5sN2CHzfOpoxXW8OBnf9YA7Rpqts7sLcyoxOhylBSmOmijIkjCf8y7-YRISbKkeLCgZf1klvfWihVqJV-feut7cGD_vnwLD4bjE634WF7Qs69HejMfy3MG0zt5ulus4EYfLvrPfsPqVFc-Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGJk1ICMG4hY3ND7AH1KiO7djOw4QK3VgZrSq0SXvLktiWKoZbSCvU_8Af419xnEurSWxve0t17CTq53OxT853EHpr8rjIIkvCWGkDGxQtQhUxESaUGhplFmyiL3AejsTpBf9yGV9uoL9tLYz_rLK1iZWh1tPCn5F3wRUlImaSd23zVcS4f_Jh9jP0DaR8orXtppE1XRb0UcU21tR4nJnlb9jNlUeDPkD_jtKT4_NPp2HTcCAswI_NQxYLxo0UOThBnuucmiyLmJKayVxyrqmNYslAahS1wiQs00SYwqo8KayJCIP7PkBbEpw-7AO3Ph6Pxt_WboH7itD6h4CwpOaHZr66LVZtvpVU9KbUd1yojhBjFqobHvPRLCsBPFt33bg9LK7c48kT9LiJa3GvXohP0YZxO2h72GTud9DhuObIXnbw-brkq-zgQzxes2cvn6E_AwcWs2Ixn-Opxb3huNf97mu85qaDR8N-r4Mzp_GPz9eLGIO9NjPfMAhPHIZYFjvPz7woMeDje524EnueTi8tFiacOA1LWcO0iatKqdqngFuARxhcGuNzB348qEb5HF3cC4Iv0KabOvMK4SSzIrYRRLCEc0tUAjBJmbMi4gXJcxIg0sKSFg2fum_rcZ2umKArJFN_6ZFMVYDer6bMajKRuwbv38B6PUMpxinhAdptwU8bw1OmKzUJ0N5_pAJkyufwA3SwEoNB8VmizJnpokw9XxL8ZdHtIyQEzQknNEAv6yW3fjXJuFRcvb7z1Q7QNuhu-nUwOttFD9vDchLtoc35r4V5A1HePN9v9Aejq_tW2X9iqWE9 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Involvement+of+AMPA%2Fkainate%2C+NMDA%2C+and+mGlu5+receptors+in+the+nucleus+accumbens+core+in+cue-induced+reinstatement+of+cocaine+seeking+in+rats&rft.jtitle=Psychopharmacology&rft.au=B%C3%A4ckstr%C3%B6m%2C+Pia&rft.au=Hyyti%C3%A4%2C+Petri&rft.date=2007-07-01&rft.issn=0033-3158&rft.eissn=1432-2072&rft.volume=192&rft.issue=4&rft.spage=571&rft.epage=580&rft_id=info:doi/10.1007%2Fs00213-007-0753-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00213_007_0753_8 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |